234751-02-1

Basic information

• Product Name: 4-Isopropylamino-3-nitro-benzoic acid methyl ester
• Synonyms: 4-Isopropylamino-3-nitro-benzoic acid methyl ester
• CAS NO: 234751-02-1
• Molecular Formula: C₁₁H₁₄N₂O₄
• Molecular Weight: 238.23986
• Mol File: 234751-02-1.mol

Chemical Properties

• Boiling Point: 377.2±32.0 °C(Predicted)
• Appearance: /
• Density: 1.240±0.06 g/cm3(Predicted)
• PKA: -2.60±0.50(Predicted)
• CAS DataBase Reference: 4-Isopropylamino-3-nitro-benzoic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Isopropylamino-3-nitro-benzoic acid methyl ester(234751-02-1)
• EPA Substance Registry System: 4-Isopropylamino-3-nitro-benzoic acid methyl ester(234751-02-1)

Safety Data

• Hazardous Substances Data: 234751-02-1(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 453-71-4 3-nitro-4-fluorobenzoic acid 
• 75-31-0 isopropylamine 
• 329-59-9 4-fluoro-3-nitro-benzoic acid methyl ester 
• 96-99-1 4-chloro-3-nitrobenzoate 
• 14719-83-6 methyl 3-nitro-4-chlorobenzoate 
• 400-94-2 4-fluoro-3-nitrobenzoyl chloride 

Downstream Products

• 511240-22-5 3-amino-4-isopropylaminobenzoic acid methyl ester 
• 1464129-47-2 C₂₃H₂₃N₃O₂S 
• 284672-95-3 4-isopropylamino-3-nitrobenzoic acid 
• 284672-84-0 1-isopropyl-1H-benzoimidazole-5-carboxylic acid methyl ester 

Relevant articles and documents

Theoretical and experimental design of atypical kinase inhibitors: Application to p38 MAP kinase

Mimics of the benzimidazolone nucleus found in inhibitors of p38 kinase are proposed, and their theoretical potential as bioisosteres is described. A set of calculated descriptors relevant to the anticipated binding interaction for the fragments 1-methyl-

Synthesis and applications of novel aminopyrazole derivative

The invention discloses a novel kinase inhibitor aminopyrazole derivative, a preparation method and medical applications thereof, and more specifically relates to an aminopyrazole derivative containing benzimidazole, and a preparation method thereof, wher

Design, synthesis and biological evaluation: 5-amino-1h-pyrazole-1-carbonyl derivatives as fgfr inhibitors

Background: Fibroblast growth factors (FGFs) and their high affinity receptors (FGFRs) play a major role in cell proliferation, differentiation, migration, and apoptosis. Aberrant FGFR signaling pathway might accelerate development in a broad panel of mal

Oxygen-containing five-membered heterocyclic compound, synthesis method, pharmaceutical composition and application

The invention discloses an oxygen-containing five-membered heterocyclic compound, a synthesis method, a pharmaceutical composition and application thereof, and belongs to the technical field of medicines and preparation and application thereof. The oxygen-containing five-membered heterocycle has the biological activity of inhibiting the protein tyrosine phosphatase SHP2, can be used as a tool compound for researching the biological function relevance of the protein tyrosine phosphatase SHP2 in the cell signal transduction process, and provides a new means for preventing and treating cancers and metabolic and immune diseases.

Synthesis of Aminofuran-Linked Benzimidazoles and Cyanopyrrole-Fused Benzimidazoles by Condition-Based Skeletal Divergence

A condition-based skeletal divergent synthesis was explored to achieve skeletal diversity in two component condensation reaction. Cyanomethyl benzimidazole was reacted with α-bromoketone under thermal conditions to furnish 2-aminofuranyl-benzimidazoles, w

Diversity-Oriented Synthesis of Coumarin-Linked Benzimidazoles via a One-Pot, Three-Step, Intramolecular Knoevenagel Cyclization

Diversity-oriented synthesis of coumarin-linked benzimidazoles from N-(2-aminophenyl)-2-cyanoacetamide was achieved via a one-pot, three-step sequential reaction in excellent yields. In situ intramolecular cyclization of the cyanoacetamide afforded benzimidazoles which subsequently underwent a Knoevenagel condensation of the 2-cyanomethylbenzimidazoles with salicylaldehydes promoted by triethylamine to reach the target compounds. An important intermediate, 2-(2-imino-2H-chromen-3-yl)-1H-benzimidazole was characterized by X-ray analysis and further hydrolyzed to 2-(coumarin-3-yl)benzimidazole in acidic condition. Among the synthesized compounds, some were found to be promising inhibitors of porcine kidney d-amino acid oxidase (pkDAO).

Copper catalyzed aerobic oxidative cyclization and ketonization: One pot synthesis of benzoimidazo[1,2-: A] imidazolones

A highly efficient synthesis of benzoimidazo[1,2-a]imidazolone through a novel oxidative 5-exo-dig cyclization-ketonization cascade of 2-aminobenzimidazole, aldehyde and terminal alkyne has been explored under aerobic conditions. The reaction proceeds thr

Three Component Divergent Reactions: Base-Controlled Amphiphilic Synthesis of Benzimidazole-Linked Thiazetidines and Fused Thiadiazines

A divergent reaction of 2-aminobenzimidazole with isothiocyanates and dihalomethanes has been developed for the selective synthesis of benzoimidazothiazetidine and benzoimidazothiadiazine. A single-pot reaction of 2-aminobenzimidazole in the presence of s

Synthesis and bioevaluation of pyrazole-benzimidazolone hybrids as novel human 4-Hydroxyphenylpyruvate dioxygenase inhibitors

4-Hydroxyphenylpyruvate dioxygenase (HPPD), an essential enzyme in tyrosine catabolism, is an important target for treating type I tyrosinemia. Inhibition of HPPD can effectively alleviate the symptoms of type I tyrosinemia. However, only one commercial H

A concise synthesis of 2-(2-aminothiophene)-benzimidazoles by one-pot multicomponent reaction

A one-pot synthesis of 2-aminothiophene linked benzimidazoles was achieved by utilizing 2-cyanomethyl benzimidazoles in a modified Gewald multicomponent reaction. The synthetic strategy of the reaction involved treatment of 2-(cyanomethyl)-benzimdazole wi